Komentarz do prac: Sciascio G. et al.: Efficacy of Atorvastatin... i Patti G. et al.: Atorvastatin Pretreatment Improves Outcomes... Komentarz
##plugins.themes.bootstrap3.article.sidebar##
Opublikowane:
wrz 30, 2009
##plugins.themes.bootstrap3.article.main##
Abstrakt
Brak
##plugins.themes.bootstrap3.article.details##
Jak cytować
Stępińska, J. (2009). Komentarz do prac: Sciascio G. et al.: Efficacy of Atorvastatin. i Patti G. et al.: Atorvastatin Pretreatment Improves Outcomes. Medycyna Faktów , 2(3(4), 32-34. Pobrano z https://journalsmededu.pl/index.php/jebm/article/view/2644
Numer
Dział
Artykuły
Copyright © by Medical Education. All rights reserved.
Bibliografia
1. Correia L.C., Sposito A.C., Lima J.C. et al.: Anti-inflammatory effect of atorvastatin (80 mg) in unstable angina pectoris and non-Q-wave acute myocardial infarction. Am. J. Cardiol. 2003; 92: 298-301.
2. Laufs U., Wassmann S., Hilgers S. et al.: Rapid effects on vascular function after initition and withdrawal of atorvastatin in healthy, normocholesterolemic men. Am. J. Cardiol. 2001; 88: 1306-7.
3. Weis M., Pehlivanli S., Meiser B.M. et al.: Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation. J. Am. Coll. Cardiol. 2001; 38: 814-8.
4. Patti G., Chello M., Pasceri V. et al.: Protection From Procedural Myocardial Injury by Atorvastatin Is Associated With Lower Levels of Adhesion Molecules After Percutaneous Coronary Intervention. JACC 2006; 48: 1560-1566.
2. Laufs U., Wassmann S., Hilgers S. et al.: Rapid effects on vascular function after initition and withdrawal of atorvastatin in healthy, normocholesterolemic men. Am. J. Cardiol. 2001; 88: 1306-7.
3. Weis M., Pehlivanli S., Meiser B.M. et al.: Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation. J. Am. Coll. Cardiol. 2001; 38: 814-8.
4. Patti G., Chello M., Pasceri V. et al.: Protection From Procedural Myocardial Injury by Atorvastatin Is Associated With Lower Levels of Adhesion Molecules After Percutaneous Coronary Intervention. JACC 2006; 48: 1560-1566.